Skip to main content

RECOVER: Researching COVID to Enhance Recovery

The National Institutes of Health (NIH) created the RECOVER Initiative to learn about the long-term effects of COVID.

The goal of RECOVER is to rapidly improve our understanding of and ability to predict, treat, and prevent PASC (post-acute sequelae of SARS-CoV-2), including Long COVID.

Learn more about Long COVID

People are joining the search for answers.

RECOVER is a first of its kind research initiative created specifically to address the widespread and diverse impacts of Long COVID. Thousands of children and adults - including pregnant people - have joined RECOVER studies.

RECOVER Cohort Studies

Observational cohort studies involve large groups of people, participating over several years. These cohort studies do not give a treatment or medicine to participants or change their regular health care.

Find and join a RECOVER cohort study

RECOVER Clinical Trials

Clinical trials are studies in which participants take a study drug, use a medical device, or try other approaches to help researchers learn about how the intervention affects health problems. RECOVER clinical trials may help find ways to treat Long COVID symptoms.

Learn about RECOVER clinical trials

Additional RECOVER Research

RECOVER's robust national research network also includes electronic health records studies, pathobiology studies, and tissue pathology studies.

View all RECOVER research components

We’re learning by including diverse perspectives.

Including people of all races and ethnicities, genders, ages, and locations in our research helps us understand how Long COVID affects everyone and gives us insight into who may benefit from different approaches to treating Long COVID. RECOVER is searching for answers to help everyone affected by the long-term effects of COVID.

Learn more about how RECOVER partners with patients and communities across the US

Millions of people have had COVID-19 — and in many ways, people of color have been hit hardest.

Studies show that some groups and communities are more likely to go to the hospital for health issues related to COVID-19. This is because people don't have equal access to health care and information about COVID. And some people live or work in places where they are more likely to catch COVID-19.

American Indian or Alaska Native
2.5
times more likely to go to the hospital
Black or African American
2.1
times more likely to go to the hospital
Hispanic or Latino
1.9
times more likely to go to the hospital
Asian
0.7
times more likely to go to the hospital
Source: Centers for Disease Control and Prevention

We learn more when we work together.

Groups involved with RECOVER: Health care providers, Researchers, Caregivers, People with Long COVID Symptoms, Supporting Organizations, Policymakers.

We learn more when we work together.

Teamwork is at the heart of RECOVER. Researchers, health care professionals, and organizations across the country are working together to find answers and treatments that help those with Long COVID. The task of predicting, treating, and preventing Long COVID requires people from many different disciplines working together because the mystery of Long COVID crosses over many different areas of medicine and biology.

Learn how RECOVER research works

More than
500 million
people around the world have had COVID. It’s possible that millions of them could have long-term health effects.

RECOVER News and Events

Learn about our latest research, upcoming events, and more.

September 5, 2023Research
RECOVER-NEURO enrolls first participant in trial

RECOVER-NEURO, a clinical trial examining how different interventions can help people with symptoms of cognitive dysfunction related to long COVID, has enrolled its first participant. RECOVER-NEURO is part of the RECOVER initiative, and all RECOVER clinical trials are coordinated by the Duke Clinical Research Institute (DCRI). This Phase 2 trial will focus on possible treatments to improve working memory, attention, executive functions, and information processing speed for people who have Long COVID.

Read the full news release.

recoverCOVID.org
July 31, 2023Research
RECOVER-VITAL enrolls first participant in trial

RECOVER-VITAL, a clinical trial examining if the antiviral PAXLOVID (nirmatrelvir and ritonavir) improves symptoms for people who have long COVID, has enrolled its first participant. RECOVER-VITAL is part of the RECOVER initiative and all RECOVER clinical trials are coordinated by the Duke Clinical Research Institute (DCRI). Researchers believe that viral persistence (when the virus that causes COVID-19 stays in the body and causes damage to organs or the immune system to not function properly) may cause long COVID symptoms.

Read the full news release.

recoverCOVID.org
July 31, 2023Research
NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment

The National Institutes of Health has launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months. Treatments will include drugs, biologics, medical devices, and other therapies. The trials will focus on several of the symptoms described as most burdensome by people experiencing long COVID.

Read the full news release.

recoverCOVID.org
June 9, 2023Research
RECOVER Research Q&A: RECOVER “First Look” Adult Cohort
Study

On May 25, 2023, RECOVER shared its “first look” into findings from the adult cohort study. The study, titled “Development of a Definition of Post-Acute Sequelae of SARS-CoV-2 Infection” was peer-reviewed and published in the Journal of the American Medical Association (JAMA). As a result of widespread interest in the study, a Q&A was developed to answer some of the most asked questions about this research and why it matters.

Read the Research Q&A.

recoverCOVID.org

Explore COVID-19 Resources

Find COVID-19 research information and resources.

CARING for Children with COVID Initiative: Learn about NIH's COVID-19 research priorities with children. External link.
NIH Community Engagement Alliance: Find information to help reach communities hardest hit by the pandemic. External link.
Post-COVID Conditions: Information for Healthcare Providers: Find information to help treat patients. External link.
NIH Long COVID Page: Access NIH Long COVID resources, including interactive symptom information. External link.
CDC's COVID-19 Resources: Access CDC's resources on COVID-19. External link.
Vaccines.gov: Find a COVID-19 vaccination site near you. External link.
Test to Treat: US Administration for Strategic Preparedness & Response COVID-19 Test to Treat locator. External link.
Temas de Salud: COVID-19: Find Spanish-language COVID-19 resources. External link.
Back to Top